Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;22(7):567-580.
doi: 10.1111/hiv.13095. Epub 2021 Mar 31.

Alarming rates of virological failure and HIV-1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY-study in Cameroon

J Fokam  1   2   3   4   5 , D Takou  1 , D Njume  1   5 , W Pabo  1   6 , M M Santoro  7 , A-E Njom Nlend  8 , G Beloumou  1 , S Sosso  1 , S Moudourou  1 , G Teto  1 , B Dambaya  1 , S Djupsa  1 , S Tetang Ndiang  8 , F N Ateba  9 , S C Billong  2   3   10 , C Kamta  11 , L Bala  12 , V Lambo  13 , V Tala  1   2 , C Chenwi Ambe  1   2 , M L Mpouel  1   2 , G Cappelli  14 , F Cham  4   15 , R Ndip  6 , L Mbuagbaw  5 , P Koki Ndombo  2   9 , F Ceccherini-Silberstein  7 , V Colizzi  1   7 , C-F Perno  1   4   16 , A Ndjolo  1   2
Affiliations
Free article

Alarming rates of virological failure and HIV-1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY-study in Cameroon

J Fokam et al. HIV Med. 2021 Aug.
Free article

Abstract

Objectives: Adolescents living with perinatal HIV infection (ALPHI) experience persistently high mortality rates, particularly in resource-limited settings. It is therefore clinically important for us to understand the therapeutic response, acquired HIV drug resistance (HIVDR) and associated factors among ALPHI, according to geographical location.

Methods: A study was conducted among consenting ALPHI in two urban and two rural health facilities in the Centre Region of Cameroon. World Health Organization (WHO) clinical staging, self-reported adherence, HIVDR early warning indicators (EWIs), immunological status (CD4 count) and plasma viral load (VL) were assessed. For those experiencing virological failure (VF, VL ≥ 1000 copies/mL), HIVDR testing was performed and interpreted using the Stanford HIV Drug Resistance Database v.8.9-1.

Results: Of the 270 participants, most were on nonnucleoside reverse transcriptase inhibitor (NNRTI)-based regimens (61.7% urban vs. 82.2% rural), and about one-third were poorly adherent (30.1% vs. 35.1%). Clinical failure rates (WHO-stage III/IV) in both settings were < 15%. In urban settings, the immunological failure (IF) rate (CD4 < 250 cells/μL) was 15.8%, statistically associated with late adolescence, female gender and poor adherence. The VF rate was 34.2%, statistically associated with poor adherence and NNRTI-based antiretroviral therapy. In the rural context, the IF rate was 26.9% and the VF rate was 52.7%, both statistically associated with advanced clinical stages. HIVDR rate was over 90% in both settings. EWIs were delayed drug pick-up, drug stock-outs and suboptimal viral suppression.

Conclusions: Poor adherence, late adolescent age, female gender and advanced clinical staging worsen IF. The VF rate is high and consistent with the presence of HIVDR in both settings, driven by poor adherence, NNRTI-based regimen and advanced clinical staging.

Keywords: CD4 count; Cameroon; HIV drug resistance; adherence; adolescents; antiretroviral therapy; viral load.

PubMed Disclaimer

References

    1. UNAIDS. Fact sheet 2016 Available at http://www.unaids.org/en/resources/factsheet (Geneva, Switzerland) (accessed 12 august 2020).
    1. Boerma RS, Bunupuradah T, Dow D et al. Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure. J Int AIDS Soc 2017; 20: 21930
    1. Fokam J, Billong SC, Jogue F et al. Immuno-virological response and associated factors amongst HIV-1 vertically infected adolescents in Yaoundé-Cameroon. PLoS One 2017; 12: e0187566.
    1. WHO | HIV/AIDS / WHO. Available at http://www.who.int/gho/hiv/en/ (accessed 6 December 2018).
    1. Mbanya D, Sama M, Tchounwou P. Current status of HIV/AIDS in Cameroon: how effective are control strategies? Int J Environ Res Public Health 2008; 5: 378-383.

Publication types

Substances

LinkOut - more resources